ClinicalTrials.Veeva

Menu

Spinal Cord Stimulation for Refractory Pain in Erythromelalgia

S

St. Olavs Hospital

Status

Enrolling

Conditions

Erythromelalgia

Treatments

Procedure: Burst Spinal Cord Stimulation
Procedure: Sham spinal cord stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT04039633
2019/159

Details and patient eligibility

About

Erythromelalgia is a rare disorder characterized by red, warm, and painful extremities, which is often precipitated by warm conditions. The pathophysiology is incompletely understood. The management of pain in erythromelalgia is challenging as no single therapy has been found to be effective. Response to pharmacotherapy varies, meaning that the physician has to take a stepwise trial and error approach with each patient. Consequently, this disorder is often associated with poorer health-related quality of life. There is currently no consensus or guideline on management of pain in erythromelalgia. Spinal cord stimulation is a widely applied therapy to treat severe chronic pain of various origin. Case reports and anecdotal evidence suggest that this therapy might alleviate refractory pain in patients with erythromelalgia.

The aim of this trial is to evaluate the efficacy of spinal cord stimulation for refractory pain in erythromelalgia.

Enrollment

24 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. A diagnosis of primary or idiopathic erythromelalgia
  2. Patients ≥18 years who have developed chronic pain that has remained refractory to medical treatment for ≥6 months.
  3. Minimum pain intensity of 5/10 on a numeric rating scale NRS at baseline.
  4. Successful two-week SCS testing period with tonic stimulation (≥2 points reduction in pain NRS from baseline). This means patients will experience paresthesia during the trial period of spinal cord stimulation.

Exclusion criteria

  1. Coexisting conditions that would increase procedural risk (e.g., sepsis, coagulopathy).
  2. History of laminectomy or posterior fusion at the thoracolumbar junction, where percutaneous electrode end tips are routinely placed.
  3. Abnormal pain behavior and/or unresolved psychiatric illness.
  4. Unresolved issues of secondary gain or inappropriate medication use.
  5. Unfit for participation for any other reason as judged by the study physician.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

24 participants in 2 patient groups

Burst spinal cord stimulation (SCS)
Experimental group
Description:
following implantation of a generator that sends pulses to a thin wire (lead), which delivers pulses to nerves along the spinal cord, the patients will initially undergo four six-week long periods with either burst SCS or no stimulation (sham) in a randomized order. During this period all patients will undergo two periods of SCS and sham stimulation.
Treatment:
Procedure: Burst Spinal Cord Stimulation
Procedure: Sham spinal cord stimulation
sham spinal cord stimulation (SCS)
Sham Comparator group
Description:
following implantation of a generator that sends pulses to a thin wire (lead), which delivers pulses to nerves along the spinal cord, the patients will initially undergo four six-week long periods with either burst SCS or no stimulation (sham) in a randomized order. During this period all patients will undergo two periods of SCS and sham stimulation.
Treatment:
Procedure: Burst Spinal Cord Stimulation
Procedure: Sham spinal cord stimulation

Trial contacts and locations

4

Loading...

Central trial contact

Sven M Carlsen, md prof; Sasha Gulati, md prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems